Global Radiopharmaceutical (Oral Route) Market Research Report 2024(Status and Outlook)

Global Radiopharmaceutical (Oral Route) Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Radiopharmaceutical (Oral Route) Market Size was estimated at USD 7012.98 million in 2023 and is projected to reach USD 8822.59 million by 2029, exhibiting a CAGR of 3.90% during the forecast period.

This report provides a deep insight into the global Radiopharmaceutical (Oral Route) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceutical (Oral Route) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceutical (Oral Route) market in any manner.

Global Radiopharmaceutical (Oral Route) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Market Segmentation (by Type)

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Market Segmentation (by Application)

Oncology

Cardiology

Other

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Radiopharmaceutical (Oral Route) Market
  • Overview of the regional outlook of the Radiopharmaceutical (Oral Route) Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical (Oral Route) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Radiopharmaceutical (Oral Route)
1.2 Key Market Segments
1.2.1 Radiopharmaceutical (Oral Route) Segment by Type
1.2.2 Radiopharmaceutical (Oral Route) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Radiopharmaceutical (Oral Route) Market Overview
2.1 Global Market Overview
2.1.1 Global Radiopharmaceutical (Oral Route) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radiopharmaceutical (Oral Route) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Radiopharmaceutical (Oral Route) Market Competitive Landscape
3.1 Global Radiopharmaceutical (Oral Route) Sales by Manufacturers (2019-2024)
3.2 Global Radiopharmaceutical (Oral Route) Revenue Market Share by Manufacturers (2019-2024)
3.3 Radiopharmaceutical (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radiopharmaceutical (Oral Route) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radiopharmaceutical (Oral Route) Sales Sites, Area Served, Product Type
3.6 Radiopharmaceutical (Oral Route) Market Competitive Situation and Trends
3.6.1 Radiopharmaceutical (Oral Route) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radiopharmaceutical (Oral Route) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Radiopharmaceutical (Oral Route) Industry Chain Analysis
4.1 Radiopharmaceutical (Oral Route) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Radiopharmaceutical (Oral Route) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Radiopharmaceutical (Oral Route) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceutical (Oral Route) Sales Market Share by Type (2019-2024)
6.3 Global Radiopharmaceutical (Oral Route) Market Size Market Share by Type (2019-2024)
6.4 Global Radiopharmaceutical (Oral Route) Price by Type (2019-2024)
7 Radiopharmaceutical (Oral Route) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceutical (Oral Route) Market Sales by Application (2019-2024)
7.3 Global Radiopharmaceutical (Oral Route) Market Size (M USD) by Application (2019-2024)
7.4 Global Radiopharmaceutical (Oral Route) Sales Growth Rate by Application (2019-2024)
8 Radiopharmaceutical (Oral Route) Market Segmentation by Region
8.1 Global Radiopharmaceutical (Oral Route) Sales by Region
8.1.1 Global Radiopharmaceutical (Oral Route) Sales by Region
8.1.2 Global Radiopharmaceutical (Oral Route) Sales Market Share by Region
8.2 North America
8.2.1 North America Radiopharmaceutical (Oral Route) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radiopharmaceutical (Oral Route) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radiopharmaceutical (Oral Route) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radiopharmaceutical (Oral Route) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bracco Imaging
9.1.1 Bracco Imaging Radiopharmaceutical (Oral Route) Basic Information
9.1.2 Bracco Imaging Radiopharmaceutical (Oral Route) Product Overview
9.1.3 Bracco Imaging Radiopharmaceutical (Oral Route) Product Market Performance
9.1.4 Bracco Imaging Business Overview
9.1.5 Bracco Imaging Radiopharmaceutical (Oral Route) SWOT Analysis
9.1.6 Bracco Imaging Recent Developments
9.2 Bayer
9.2.1 Bayer Radiopharmaceutical (Oral Route) Basic Information
9.2.2 Bayer Radiopharmaceutical (Oral Route) Product Overview
9.2.3 Bayer Radiopharmaceutical (Oral Route) Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Radiopharmaceutical (Oral Route) SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Radiopharmaceutical (Oral Route) Basic Information
9.3.2 Mallinckrodt Radiopharmaceutical (Oral Route) Product Overview
9.3.3 Mallinckrodt Radiopharmaceutical (Oral Route) Product Market Performance
9.3.4 Mallinckrodt Radiopharmaceutical (Oral Route) SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Nordion
9.4.1 Nordion Radiopharmaceutical (Oral Route) Basic Information
9.4.2 Nordion Radiopharmaceutical (Oral Route) Product Overview
9.4.3 Nordion Radiopharmaceutical (Oral Route) Product Market Performance
9.4.4 Nordion Business Overview
9.4.5 Nordion Recent Developments
9.5 Triad Isotopes
9.5.1 Triad Isotopes Radiopharmaceutical (Oral Route) Basic Information
9.5.2 Triad Isotopes Radiopharmaceutical (Oral Route) Product Overview
9.5.3 Triad Isotopes Radiopharmaceutical (Oral Route) Product Market Performance
9.5.4 Triad Isotopes Business Overview
9.5.5 Triad Isotopes Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radiopharmaceutical (Oral Route) Basic Information
9.6.2 Lantheus Radiopharmaceutical (Oral Route) Product Overview
9.6.3 Lantheus Radiopharmaceutical (Oral Route) Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 IBA Group
9.7.1 IBA Group Radiopharmaceutical (Oral Route) Basic Information
9.7.2 IBA Group Radiopharmaceutical (Oral Route) Product Overview
9.7.3 IBA Group Radiopharmaceutical (Oral Route) Product Market Performance
9.7.4 IBA Group Business Overview
9.7.5 IBA Group Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Radiopharmaceutical (Oral Route) Basic Information
9.8.2 GE Healthcare Radiopharmaceutical (Oral Route) Product Overview
9.8.3 GE Healthcare Radiopharmaceutical (Oral Route) Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 China Isotope and Radiation
9.9.1 China Isotope and Radiation Radiopharmaceutical (Oral Route) Basic Information
9.9.2 China Isotope and Radiation Radiopharmaceutical (Oral Route) Product Overview
9.9.3 China Isotope and Radiation Radiopharmaceutical (Oral Route) Product Market Performance
9.9.4 China Isotope and Radiation Business Overview
9.9.5 China Isotope and Radiation Recent Developments
9.10 Jubilant Pharma
9.10.1 Jubilant Pharma Radiopharmaceutical (Oral Route) Basic Information
9.10.2 Jubilant Pharma Radiopharmaceutical (Oral Route) Product Overview
9.10.3 Jubilant Pharma Radiopharmaceutical (Oral Route) Product Market Performance
9.10.4 Jubilant Pharma Business Overview
9.10.5 Jubilant Pharma Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Radiopharmaceutical (Oral Route) Basic Information
9.11.2 Eli Lilly Radiopharmaceutical (Oral Route) Product Overview
9.11.3 Eli Lilly Radiopharmaceutical (Oral Route) Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
9.12 Advanced Accelerator Applications
9.12.1 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Basic Information
9.12.2 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Overview
9.12.3 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Market Performance
9.12.4 Advanced Accelerator Applications Business Overview
9.12.5 Advanced Accelerator Applications Recent Developments
9.13 SIEMENS
9.13.1 SIEMENS Radiopharmaceutical (Oral Route) Basic Information
9.13.2 SIEMENS Radiopharmaceutical (Oral Route) Product Overview
9.13.3 SIEMENS Radiopharmaceutical (Oral Route) Product Market Performance
9.13.4 SIEMENS Business Overview
9.13.5 SIEMENS Recent Developments
9.14 Dongcheng
9.14.1 Dongcheng Radiopharmaceutical (Oral Route) Basic Information
9.14.2 Dongcheng Radiopharmaceutical (Oral Route) Product Overview
9.14.3 Dongcheng Radiopharmaceutical (Oral Route) Product Market Performance
9.14.4 Dongcheng Business Overview
9.14.5 Dongcheng Recent Developments
9.15 Navidea
9.15.1 Navidea Radiopharmaceutical (Oral Route) Basic Information
9.15.2 Navidea Radiopharmaceutical (Oral Route) Product Overview
9.15.3 Navidea Radiopharmaceutical (Oral Route) Product Market Performance
9.15.4 Navidea Business Overview
9.15.5 Navidea Recent Developments
10 Radiopharmaceutical (Oral Route) Market Forecast by Region
10.1 Global Radiopharmaceutical (Oral Route) Market Size Forecast
10.2 Global Radiopharmaceutical (Oral Route) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radiopharmaceutical (Oral Route) Market Size Forecast by Country
10.2.3 Asia Pacific Radiopharmaceutical (Oral Route) Market Size Forecast by Region
10.2.4 South America Radiopharmaceutical (Oral Route) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radiopharmaceutical (Oral Route) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Radiopharmaceutical (Oral Route) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radiopharmaceutical (Oral Route) by Type (2025-2030)
11.1.2 Global Radiopharmaceutical (Oral Route) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radiopharmaceutical (Oral Route) by Type (2025-2030)
11.2 Global Radiopharmaceutical (Oral Route) Market Forecast by Application (2025-2030)
11.2.1 Global Radiopharmaceutical (Oral Route) Sales (Kilotons) Forecast by Application
11.2.2 Global Radiopharmaceutical (Oral Route) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings